CIK 0001704287 · <br>Emerging growth company
Bluejay Diagnostics, Inc.
Sign in to watch- Ticker
- BJDX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473552922
- Phone
- (978) 631-0152
- Business address
- 360 MASSACHUSETTS AVENUE, SUITE 203, ACTON, MA, 01720
- 4/A Open-market buy President and CEO bought 10,000 shares at $0.44 ($4,400)
- 4 Grant or award President and CEO acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 27,500 shares (grant or award)
- 4 Grant or award Director acquired 27,500 shares (grant or award)
- 4 Grant or award Director acquired 27,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 159,090 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 112,500 shares (grant or award)
- 4 Grant or award Director acquired 27,500 shares (grant or award)
- 4 Grant or award Director acquired 27,500 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at $1.03 ($20,600)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at $0.99 ($19,800)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 3 · 59 filings